| ATM | Ataxia-Telangiectasia Mutated |
| ATR | Ataxia Telangiectasia and Rad3 Related |
| BD | Bromodomain |
| BET | Bromodomains and Extraterminal |
| BRCA1 | Breast Cancer 1 |
| BRCT | BRCA1 Carboxy-Terminus |
| CCNK | Cyclin K |
| CDK | Cyclin-Dependent Kinase |
| ChIP | Chromatin Immunoprecipitation |
| CHD4 | Chromodomain Helicase DNA-binding Protein 4 |
| CK2 | Casein Kinase 2 |
| CML | Chronic Myelogenous Leukemia |
| CTD | C-Terminal Domain |
| CtIP | CtBP-Interacting Protein |
| DNA | Deoxyribonucleic acid (necessary?) |
| DNA-PKcs | DNA-dependent Protein Kinase Catalytic Subunit |
| DSB | Double-Strand Break |
| ET | Extraterminal Domain |
| GBM | Glioblastoma Multiforme |
| H2AX | Histone 2AX |
| HR | Homologous Recombination |
| HRR | Homologous Recombination Repair |
| H3K9Ac | Histone H3 at lysine 9 |
| IR | Ionizing Radiation |
| NHEJ | Non-Homologous End Joining |
| PALB2 | Partner and Localizer of BRCA2 |
| PARPi | Poly (ADP-ribose) Polymerase Inhibitors |
| PLK1 | Polo-like kinase 1 |
| RB | Retinoblastoma |
| RPA | Replication Protein A |
| SE | Super-Enhancers |
| ssDNA | Single-Strand DNA |
| TCGA | The Cancer Genome Atlas |
| UV | Ultra-violet |
| 53BP1 | TP53-binding protein |